The Latest Breaking News from telehealth

The safety of abortion drugs is well-established, but an upcoming SCOTUS ruling could unravel decades of precedent

Telehealth company Hims & Hers is trading near record highs after issuing strong guidance for the full year ahead. With the stock up nearly 145% in the last six months, how much more upside is left for HIMS?

GPs say patients should be able to fill scripts at any pharmacy and that a health professional should be consulted first

States next to other states with total ban have seen largest increase in rates, while US telehealth abortion rates also grew

The study looks at 6,000 patients who got abortion pills after an online appointment. It found that 99.7% of those abortions were not followed by any serious adverse events.

An analysis of more than 6,000 telehealth abortion recipients in the U.S. suggests that receiving the abortion drugs via a virtual doctor's appointment is as safe and effective as doing so in person.

Laws protecting doctors for being prosecuted for providing assisted dying services over the phone or by telehealth have been introduced to parliament.

Pro BRAVIA displays are deployed in clients’ homes where they are used with the company’s “Clinic@Home” telehealth.

The Supreme Court will soon decide the fate of access for mifepristone. The fallout of a ban would be tremendous

Patients frequently describe the U.S. health care system as impersonal, corporate and fragmented. One study even called the care delivered to many vulnerable patients “inhumane.” Seismic changes caused by the COVID-19 pandemic – particularly the shift to telehealth – only exacerbated that feeling.

For the patient, it was a quick and inexpensive virtual appointment. Why it cost 10 times more than she expected became a mystery.